Ruikang Pharmaceuticals: The accumulated repurchase of company shares has reached 2.03%.

Rui Kang Pharmaceutical announced that as of November 4, 2025, the company has repurchased a total of 30.5049 million shares through centralized bidding trading, accounting for 2.03% of the company's current total share capital. The highest transaction price was 3.08 yuan per share, the lowest transaction price was 2.75 yuan per share, and the transaction amount was 89.2961 million yuan. The repurchase implementation meets the requirements of the company's share repurchase program and relevant laws and regulations.